Please contact the Marketing and Communications office with media inquiries.
P: (405) 271-1333
C: (405) 213-6411
What if a smartphone app could help you avoid relapsing back to smoking even before you knew you were at risk? A researcher from the Oklahoma Tobacco Research Center at the Stephenson Cancer Center is developing smartphone-based technology to help people receive real-time tobacco cessation treatment when they are most at risk.
At the University of Oklahoma Health Sciences Center in Oklahoma City, a team of health professionals and researchers has launched a new trial to compare different prehabilitation approaches for patients about to undergo surgery for pancreatic cancer. Pancreatic cancer is an especially difficult disease, with survival rates under 7 percent.
Nearly 7 in 10 cigarette smokers are looking for a way to quit – and many smokers have turned to e-cigarettes for help. A researcher at the Oklahoma Tobacco Research Center at the Stephenson Cancer Center has received a 5-year, $3 million R01 grant from the National Cancer Institute to study the impact of e-cigarette usage on smoking rates.
A new $562,825 federal grant advances research aimed at making vaccines against melanoma a reality for more patients. The work also may help bring clinical trials of those new vaccines to Oklahoma.
Michael Cookson, MD, professor and chair of the department of Urology at the University of Oklahoma College of Medicine, has been elected to the Society for Pelvic Surgeons. Cookson also holds the Donald D. Albers Chair and is director of Prostate and Urologic Cancer Services at Stephenson Cancer Center.
We'll send you newsletters with the latest news and information about the Stephenson Cancer Center, special features on physicians and clinics, tips for a healthy lifestyle and special events.
The University of Oklahoma is an Equal Opportunity Employer |